Second-look Surgery for Residual Tumors in Diffuse Glioma Patients
Overview
This retrospective study evaluates the safety and efficacy of early second-look surgery within six weeks for unexpected residual tumors in diffuse glioma patients. Among 1,558 patients treated surgically, 46 underwent early re-resection, demonstrating that timely second-look surgery can improve tumor resection without significantly compromising neurological function.
Background
Neurosurgical resection plays a critical role in managing diffuse gliomas, with evidence supporting maximal removal of both contrast-enhancing and non-contrast-enhancing tumor components to improve progression-free and overall survival. However, delineating tumor margins intraoperatively remains challenging due to diffuse infiltration and eloquent brain areas. Early postoperative MRI often reveals unexpected residual tumor, posing a dilemma about the safety and benefit of early re-resection. This study addresses the clinical outcomes of unplanned second-look surgeries performed within six weeks after initial resection.
Data Highlights
Parameter
Value
Total glioma patients surgically treated (2013-2023)
1,558
Patients with ≥1 re-operation
447
Patients undergoing early second-look surgery (≤6 weeks)
46
Definition of second-look surgery
Re-intervention due to residual tumor on early postoperative MRI
Key Findings
Early second-look surgery was performed in 46 patients due to unexpected residual tumor detected on postoperative MRI.
Decisions for re-resection were individualized based on resectability, eloquence, patient performance status, and surgical safety rather than fixed volumetric thresholds.
Extent of resection was assessed using advanced volumetric MRI techniques distinguishing contrast-enhancing and non-contrast-enhancing tumor compartments.
Second-look surgery allowed for further tumor volume reduction, potentially improving progression-free and overall survival.
Functional outcomes were monitored using Karnofsky Performance Score and NIH Stroke Scale to ensure neurological safety.
Early re-resection may compensate for incomplete initial surgery, especially in glioblastoma patients, aligning with prognostic markers such as RANO resect classification.
Clinical Implications
Early second-look surgery can be a viable option for managing unexpected residual tumor in diffuse glioma patients, enabling improved tumor control without significantly increasing neurological risk. Multidisciplinary evaluation and advanced imaging are essential to guide individualized surgical decisions. This approach supports maximizing extent of resection while preserving patient function.
Conclusion
Unplanned early second-look surgery within six weeks after initial resection is a feasible and effective strategy to address residual tumors in diffuse glioma patients. It offers an opportunity to enhance tumor removal and potentially improve survival outcomes while maintaining neurological safety.
References
Honeyman et al. 2024 -- Prognostic impact of re-resection extent in glioblastoma
Ringel 2016 -- Role of re-resection in glioblastoma management
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
